MORE than two million Australians living with osteoporosis1 are set to benefit from the first once-a-month osteoporosis therapy, after it was today listed on the Pharmaceutical Benefits Scheme (PBS).
01/07/2009
RESEARCHERS at the National Space Biomedical Research Institute (NSBRI) developing an ultrasound device which will assist the fight against bone disorders.
19/02/2009
Roche has announced that its Phase III clinical trial evaluation of ocrelizumab as a treatment for seropositive rheumatoid arthritis (RA) patients with a previous inadequate response to methotrexate (MTX), has met its primary efficacy endpoint.
14/12/2009
An Australian regenerative medicine company, Mesoblast, has been granted a key patent by the United States Patent and Trademark Office (USPTO), providing them with exclusive commercial protection for its bone tissue generating products through to at least 2019 in the US.
05/03/2010